Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2009
09/30/2009CN101544648A 3a-(trifluoromethyl)-2,3,3a,4-tetrahydro-1H-benzene[d]pyrrole[1,2-a]imidazole-1-ketone and synthesis method thereof
09/30/2009CN101544647A (4aR,8aR)-3a-(difluoromethyl)decahydro-1H-benzene[d]pyrrole[1,2-a]-thiazole-1-ketone and synthesis method thereof
09/30/2009CN101544646A 3a-(difluoromethyl)-2,3,3a-tetrahydro-1H-benzene[d]pyrrole[1,2-a]thiazole-1-ketone and synthesis method thereof
09/30/2009CN101544645A 6-flourine-3a-(trifluoromethyl)-2,3,3a,4-tetrahydro-1H-benzo[d]pyrrole[1,2-a]imidazole-1-ketone and method for synthesizing same
09/30/2009CN101544644A Preparation method of mianserin hydrochloride
09/30/2009CN101544643A New method of synthesizing 1, 2, 3-triazol 1, 3-diazacyclo compound
09/30/2009CN100545162C Antipyretic analgesic and anti-arthritis nonsteroidal compound and its pharmaceutical compositions
09/30/2009CN100545160C Diamine derivatives
09/29/2009US7595407 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
09/29/2009US7595400 Synthesis of antitumor agents including camptothecin derivative 9-ethyl-9-hydroxy-1-pentyl-1H,12H-pyrano[3'',4'':6',7']-indolizino[1',2':6,5]pyrido[4,3,2-de]quinazoline-10,13(9H,15H)-dione
09/29/2009US7595395 Dementia and Alzheimer's disease; alpha 5 subtype specific inverse agonists of GABA(A); compounds based on imidazo(1,5-a)-3H-1,4-benzodiazepine
09/29/2009US7595394 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595336 Isatine derivatives with neurotrophic activity
09/29/2009US7595325 1-[5-(4-Amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-pyridin-3-yl]-3-(2-fluoro-5-methyl-phenyl)-urea; cancer
09/29/2009US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example
09/29/2009US7595311 Azepinoindole derivatives as pharmaceutical agents
09/29/2009CA2473962C Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material
09/29/2009CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt
09/29/2009CA2457944C Polycyclic guanine phosphodiesterase v inhibitors
09/29/2009CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors
09/24/2009WO2009117540A1 Bridged heterocycles as hiv integrase inhibitors
09/24/2009WO2009117482A1 Mtor inhibitor salt forms
09/24/2009WO2009117352A1 Cancer treatment method
09/24/2009WO2009117157A1 Aurora kinase modulators and method of use
09/24/2009WO2009117156A1 Pyrazolo-pyrazinone compounds and methods of use thereof
09/24/2009WO2009117144A1 Benzazepine compounds
09/24/2009WO2009117097A1 Novel tyrosine kinase inhibitors
09/24/2009WO2009116377A1 Organic electroluminescent device
09/24/2009WO2009116071A2 An improved process for preparation of paliperidone
09/24/2009WO2009115321A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
09/24/2009WO2009097233A9 Imidazopyrazines as protein kinase inhibitors
09/24/2009WO2009076440A3 Fungicidal bicyclic pyrazoles
09/24/2009WO2009070314A3 Crystalline form of sitagliptin
09/24/2009WO2008113469A8 Substituted imidazopyrimidines and triazolopyrimidines
09/24/2009WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
09/24/2009US20090239896 Azaindole compounds and use thereof as phospholipase-a2 inhibitors
09/24/2009US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases
09/24/2009US20090239883 Treatment of Pulmonary Hypertension
09/24/2009US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one
09/24/2009US20090239870 Spirohydantoin Aryl Cgrp Receptor Antagonists
09/24/2009US20090239853 Fused heterocycle derivative
09/24/2009US20090239846 Novel Compounds
09/24/2009US20090239845 Pyrazole compounds as prostaglandin receptors ligands
09/24/2009US20090239843 Bridged diazepan orexin receptor antagonists
09/24/2009US20090239824 Hydrolytically-resistant boron-containing therapeutics and methods of use
09/24/2009CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
09/24/2009CA2718950A1 Bridged heterocycles as hiv integrase inhibitors
09/24/2009CA2718872A1 Novel tyrosine kinase inhibitors
09/24/2009CA2718558A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as_melanocortin-4 receptor modulators
09/24/2009CA2716924A1 Mtor inhibitor salt forms
09/24/2009CA2716856A1 Aurora kinase modulators and method of use
09/23/2009EP2103614A1 Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
09/23/2009EP2103613A1 Quinoxaline derivative
09/23/2009EP2102212A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
09/23/2009EP2102211A2 Heterobicyclic metalloprotease inhibitors
09/23/2009EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/23/2009EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
09/23/2009EP2101768A2 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
09/23/2009EP1699797B1 Pyrrolotriazine compounds as kinase inhibitors
09/23/2009EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/23/2009EP1380293A9 Bone metabolism improving agents
09/23/2009CN101541807A Spiro benzazepines as vasopressin antagonists
09/23/2009CN101541806A Spiro benzazepines used as vasopressin antagonists
09/23/2009CN101541805A Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
09/23/2009CN101541804A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
09/23/2009CN101541803A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
09/23/2009CN101541802A Substituted 2,5-dfflydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation and therapeutic use of the same
09/23/2009CN101541801A Fused heterocyclic derivative and use thereof
09/23/2009CN101538269A Recovery method for dealcoholizing waste water in glycine technology of chloroactic acid method
09/23/2009CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
09/23/2009CN101537007A Application of N-(thiofuran-2) pyrazolo (1, 5-a) pyridine-3-formanides compounds for preparing antineoplastic
09/23/2009CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives
09/22/2009US7592454 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
09/22/2009US7592448 Mono amine and diamine derivatives of CL-20
09/22/2009US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
09/22/2009US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
09/22/2009US7592340 Quinoxalines useful as inhibitors of protein kinases
09/22/2009US7591888 Having sulfo-substituted anilino group, and sulfo-substituted anilino group has a substituted triazinyl group; light fastness, ozone fastness and moisture fastness, does not cause bronzing phenomenon
09/22/2009CA2523960C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
09/22/2009CA2400236C Use of indoloquinoxaline derivatives for preparing a drug for the treatment of multiple sclerosis
09/17/2009WO2009114575A1 Tricyclic spiro pyrimidine derivatives as histamine h4 ligand
09/17/2009WO2009114512A1 Azetidine and cyclobutane derivatives as jak inhibitors
09/17/2009WO2009114180A1 Inhibitors of the bmp signaling pathway
09/17/2009WO2009113580A1 Rna-selective hybridization reagent and utilization of the same
09/17/2009WO2009113560A1 Fused heterocyclic compound
09/17/2009WO2009113511A1 Liquid porphyrin derivative and method for producing the same
09/17/2009WO2009113423A1 Bicyclic pyrrole compound
09/17/2009WO2009113109A1 New phenanthrylphenol linked pyrrolo[2,l-c][l,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
09/17/2009WO2009113084A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof
09/17/2009WO2009112845A1 Amido-thiophene compounds and their use
09/17/2009WO2009112462A2 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
09/17/2009WO2009111943A1 The compounds as the estrogen related receptors modulators and the uses thereof
09/17/2009WO2009089263A3 Novel compositions and methods of use
09/17/2009WO2009080836A3 Macrocyclic indoles as hepatitis c virus inhibitors
09/17/2009WO2009044007A3 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof
09/17/2009US20090234137 Total synthesis of salinosporamide a and analogs thereof
09/17/2009US20090234123 Processes For The Preparation Of Clopidogrel Hydrogen Sulfate Polymorphic Form I
09/17/2009US20090234117 Pyrazolopyrimidine Derivative
09/17/2009US20090233948 Inhibitors of nucleoside phosphorylases and nucleosidases